Flurofamide

CAS No. 70788-28-2

Flurofamide( —— )

Catalog No. M26217 CAS No. 70788-28-2

Flurofamide is an effective bacterial urease inhibitor and has potential in the treatment of infected urinary calculi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 33 In Stock
2MG 29 In Stock
5MG 42 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Flurofamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Flurofamide is an effective bacterial urease inhibitor and has potential in the treatment of infected urinary calculi.
  • Description
    Flurofamide is an effective bacterial urease inhibitor and has potential in the treatment of infected urinary calculi.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    70788-28-2
  • Formula Weight
    217.14
  • Molecular Formula
    C7H9FN3O2P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 14.29 mg/mL (65.81 mM)
  • SMILES
    NP(N)(=O)NC(=O)c1ccc(F)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Christophersen PC, Zhang L, Müllertz A, Nielsen HM, Yang M, Mu H. Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation. Pharm Res. 2014 Sep;31(9):2420-8.
molnova catalog
related products
  • 1-methyl-4-quinolone

    1-methyl-4-quinolone

  • GPLGIAGQ TFA

    GPLGIAGQ TFA, is an MMP2-cleaved polypeptide that is used as a stimulus-sensitive connector in both liposomes and micelle nanoceroses for targeted therapy of tumors triggered by MMP2.

  • Emoxipine

    Emoxipine is an antidepressant agent.The influence of emoxipine (2-ethyl-6-methyl-3-hydroxypyridine hydrochloride) and mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) on the content of lipid peroxidation products in peripheral blood and the dynamics of clinical symptoms of gastrointestinal tract pathology has been studied in patients of middle and senile age with atherosclerosis in the abdominal aorta.